AP-472
Neurological Disorder (unspecified)
Phase 1Active
Key Facts
About Appello Pharmaceuticals
Appello Pharmaceuticals is a private, pre-revenue biotechnology company targeting the high-unmet-need area of neurological disorders. The company leverages contemporary neuroscience research to build a pipeline of small molecule drugs, with its lead program, AP-472, having advanced into clinical development. Appello positions itself as a leader aiming to catalyze a paradigm shift in neurology treatment this decade, though it operates in a notoriously challenging and competitive therapeutic area with high clinical and regulatory risk.
View full company profile